Dr. Reddy's Laboratories
Search results
Mankind Pharma is one of the Indian leading pharmaceutical companies, and changes the pharma industry by providing world class medications at affordable prices and maintaining quality standards by using state-of-the-art technology for production of high-quality medicines.
Mankind Pharma focuses on a variety of therapeutic segments such as Cardiovascular, Antibiotics, Gastro-intestinal, Anti-allergic, Anti-fungal, Nutritional, NSAIDs, Ortho and Gynaecological. Every day 75 Lacs Indians consume Mankind's cardiac care products.
Mankind Pharma, Best pharmaceutical company in India, has a wide range of products like Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular Dermal, Erectile Dysfunction etc.
Mankind Pharma is an Indian pharmaceutical and healthcare products company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics , to gastrointestinal , cardiovascular , dermal , and erectile dysfunction medications.
2 days ago · Mankind Pharma share price was Rs 2,108.00 as on 27 Jun, 2024, 02:27 PM IST. Mankind Pharma share price was down by 1.48% based on previous share price of Rs 2,128.2. Mankind Pharma share price trend: Last 1 Month: Mankind Pharma share price moved down by 0.30%; Last 3 Months: Mankind Pharma share price moved down by 9.77%
4 days ago · Mankind Pharma Limited Stock Price Today, Live NSE Share Price: Get the latest Mankind Pharma Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Nov 14, 2023 · Pharma. In May this year, Rajeev and Ramesh Juneja's Mankind Pharma became India's biggest IPO by value. From building the company ground up, Mankind Pharma—which is No 4 in revenue and...
Get the latest Mankind Pharma Ltd (MANKIND) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jan 31, 2024 · Mankind Pharma, which also makes acute and chronic therapeutics, including anti-infectives, anti-diabetics and respiratory therapeutics, said revenue from operations rose 25% to 26.07...
In our domestic pharmaceuticals business, our product portfolio comprises a broad range of formulations across various acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients and respiratory.
